Pharmaceutical industry
Pfizer Outlines Strength and Long-Term Outlook Ahead of Warner-Lambert Merger
Pfizer Inc. has outlined its strength and excellent long-term outlook to shareholders, citing the proposed merger with Warner-Lambert as a key factor in creating a global leader with a market capitalisation of over $300 billion. The company's chairman and CEO, William C. Steere Jr., and CEO and President,